Latest Breaking News On - Chemrex corporation sdn bhd - Page 1 : comparemela.com

BioNexus Gene Lab Corp Announces Closing of $5 75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market

BioNexus Gene Lab Corp Announces Closing of $5 75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Kuala lumpurRepublic ofNew jerseyUnited statesKeith testaverdeMatthew abenanteFinancial securities incStrategic investor relationsOrtoli rosenstadtRed bankBionexus gene lab corpCompany nasdaqCompany contactExchange commission onChemrex corporation sdn bhdNexus gene lab

BioNexus Gene Lab Corp Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market

BioNexus Gene Lab Corp Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Republic ofNew jerseyUnited statesKuala lumpurMatthew abenanteAdam pasholkCompany contactFinancial securities incOrtoli rosenstadtChemrex corporation sdn bhdStrategic investor relationsBionexus gene lab corpRed bankExchange commissionNexus gene labSoutheast asia

BioNexus Gene Lab Corp Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market

BioNexus Gene Lab Corp Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Republic ofKuala lumpurNew jerseyUnited statesAdam pasholkMatthew abenanteChemrex corporation sdn bhdIrcpresidentstrategic investor relationsFinancial securities incRed bankBionexus gene lab corpExchange commissionOrtoli rosenstadtCompany contactNexus gene labSoutheast asia

BioNexus Gene Lab Corp Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market - BioNexus Gene Lab (OTC:BGLC)

KUALA LUMPUR, Malaysia, July 20, 2023 (GLOBE NEWSWIRE) BioNexus Gene Lab Corp. ("BioNexus" or the "Company"), an emerging company in the business of selling chemical raw materials in the Southeast Asia region and

Republic ofKuala lumpurNew jerseyUnited statesAdam pasholkMatthew abenanteExchange commissionFinancial securities incStrategic investor relationsBionexus gene lab corpRed bankChemrex corporation sdn bhdOrtoli rosenstadtCompany contactNexus gene labSoutheast asia

BioNexus Gene Lab Corp Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market

KUALA LUMPUR, Malaysia, July 20, 2023 (GLOBE NEWSWIRE) BioNexus Gene Lab Corp. (“BioNexus” or the “Company”), an emerging company in the business of selling chemical raw materials in the Southeast Asia region and the development of safe, effective, and non-invasive liquid biopsy tests for early diagnosis and personalized health management, today announced the pricing of its Public Offering (the “Offering”) of 1,250,000 shares of common stock at a price of $4.00 per share for total gross proce

Kuala lumpurNew jerseyUnited statesRepublic ofAdam pasholkMatthew abenanteBionexus gene lab corpFinancial securities incExchange commissionStrategic investor relationsRed bankOrtoli rosenstadtChemrex corporation sdn bhdCompany contactNexus gene labSoutheast asia